Creo Medical Group PLC (AIM:CREO)
16.75
-0.38 (-2.19%)
At close: Feb 12, 2026
Creo Medical Group Market Cap
Creo Medical Group has a market cap or net worth of 67.41 million as of February 12, 2026. Its market cap has decreased by -6.87% in one year.
Market Cap
67.41M
Enterprise Value
51.11M
Revenue
4.60M
Ranking
n/a
PE Ratio
75.96
Stock Price
16.75
Market Cap Chart
Since December 9, 2016, Creo Medical Group's market cap has increased from 64.46M to 67.41M, an increase of 4.59%. That is a compound annual growth rate of 0.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 68.92M | 72.98% |
| Dec 31, 2025 | 39.84M | -49.19% |
| Dec 31, 2024 | 78.42M | -51.05% |
| Dec 29, 2023 | 160.20M | 255.34% |
| Dec 30, 2022 | 45.08M | -83.01% |
| Dec 31, 2021 | 265.37M | -13.37% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 9, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 229.82B |
| GSK plc | 86.28B |
| Haleon | 36.19B |
| Smith & Nephew | 10.94B |
| 4basebio | 91.32M |
| Venture Life Group | 87.37M |
| INSPECS Group | 75.75M |
| ECO Animal Health Group | 73.18M |